HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ulrich Schraermeyer Selected Research
Ulrich Schraermeyer Research Topics
Disease
15
Macular Degeneration (Age-Related Maculopathy)
01/2023 - 05/2002
5
Stargardt Disease
01/2023 - 08/2013
4
Choroidal Neovascularization
11/2020 - 10/2002
3
Retinal Degeneration
01/2023 - 10/2002
3
Eye Diseases (Eye Disease)
01/2022 - 02/2013
3
Blindness (Hysterical Blindness)
12/2020 - 10/2012
3
Ganglion Cysts (Ganglion)
12/2015 - 12/2007
2
Ischemia
01/2022 - 11/2006
2
Hypoxia (Hypoxemia)
01/2022 - 01/2019
2
Rupture
01/2018 - 10/2002
2
Retinoblastoma (Glioblastoma, Retinal)
01/2017 - 11/2016
2
Inflammation (Inflammations)
12/2016 - 07/2002
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1
Pathologic Neovascularization
01/2022
1
Demyelinating Diseases (Demyelinating Disease)
11/2019
1
Myopia
11/2019
1
Refractive Errors (Refractive Error)
11/2019
1
Malaria
01/2019
1
Intussusception
01/2019
1
Cerebral Malaria
01/2019
1
Endophthalmitis (Ophthalmia)
12/2016
1
Arthrogryposis renal dysfunction cholestasis syndrome
02/2016
1
Hemolysis
06/2014
1
Hypertrophy
06/2014
1
Retinal Diseases
08/2013
1
Thrombotic Microangiopathies
09/2012
1
Papilledema
07/2008
1
Glaucoma
12/2007
1
Macular Edema
06/2007
1
Atrophy
02/2007
1
Blister (Bulla)
11/2006
1
Retinal Detachment (Retinal Detachments)
11/2006
1
Leukostasis
09/2004
1
Diabetic Retinopathy (Retinopathy, Diabetic)
09/2004
1
Cicatrix (Scar)
12/2003
Drug/Important Bio-Agent (IBA)
10
Retinaldehyde (Retinal)
IBA
01/2022 - 09/2004
8
Lipofuscin
IBA
01/2023 - 01/2011
6
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2020 - 10/2007
4
Bevacizumab (Avastin)
FDA Link
11/2020 - 06/2007
3
Melanins (Melanin)
IBA
01/2023 - 10/2005
3
soraprazan
IBA
01/2022 - 12/2020
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 07/2002
3
Retinal Pigments (Pigments, Visual)
IBA
01/2017 - 05/2002
2
Trace Elements (Biometals)
IBA
01/2018 - 07/2011
2
Ranibizumab (Lucentis)
FDA Link
06/2014 - 10/2007
1
pigment epithelium-derived factor
IBA
01/2022
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
11/2019
1
Tyrosine (L-Tyrosine)
FDA Link
01/2017
1
hydroxide ion
IBA
01/2017
1
Retinoids
IBA
01/2017
1
Immunoglobulin Fc Fragments
IBA
12/2016
1
Eosine Yellowish-(YS) (Eosin)
IBA
11/2016
1
Hematoxylin (Haematoxylon)
IBA
11/2016
1
Lipid Bilayers (Lipid Bilayer)
IBA
02/2016
1
Iron
IBA
08/2015
1
aflibercept
IBA
06/2014
1
Antigen-Antibody Complex (Immune Complex)
IBA
09/2012
1
Zinc
IBA
07/2011
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
07/2008
1
neogenin
IBA
12/2007
1
Antigens
IBA
10/2007
1
Solutions
IBA
11/2006
1
Edetic Acid (EDTA)
FDA Link
11/2006
1
Saline Solution
IBA
11/2006
1
Cell Adhesion Molecules
IBA
09/2004
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
09/2004
1
Platelet Endothelial Cell Adhesion Molecule-1
IBA
12/2003
1
Dextrans (Dextran)
FDA Link
12/2003
1
fluorescein isothiocyanate dextran
IBA
12/2003
1
Peroxidase (Myeloperoxidase)
IBA
12/2003
1
Oxygen (Dioxygen)
IBA
10/2002
1
Rhodopsin (Visual Purple)
IBA
10/2002
Therapy/Procedure
4
Intravitreal Injections
01/2022 - 09/2012
2
Therapeutics
01/2017 - 10/2007
2
Lasers (Laser)
12/2003 - 10/2002
2
Transplantation
10/2002 - 05/2002
1
Lenses
11/2019
1
Radiotherapy
01/2017
1
Microelectrodes
12/2015
1
Vitrectomy
11/2006
1
Autologous Transplantation
10/2002